<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01066208</url>
  </required_header>
  <id_info>
    <org_study_id>ACREULAR001</org_study_id>
    <nct_id>NCT01066208</nct_id>
  </id_info>
  <brief_title>American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis</brief_title>
  <acronym>DCVAS</acronym>
  <official_title>ACR/EULAR Endorsed Study to Develop New Diagnostic and Classification Criteria for Primary Systemic Vasculitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Rheumatology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The European League Against Rheumatism (EULAR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Vasculitis foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vasculitis is group of diseases where inflammation of blood vessels is the common feature.
      Patients typically present with fever, fatigue, weakness and muscle and joint aches. These
      symptoms are very common among many different diseases, not just vasculitis. A clustering of
      other symptoms, physical examination findings, blood tests, radiology and biopsy help make
      the diagnosis. There are currently no criteria to help doctors make a diagnosis of vasculitis
      when a patient presents with these non specific symptoms and they are reliant on previous
      experience and disease definitions. One of the aims of this project is to develop diagnostic
      criteria for the primary systemic vasculitides (granulomatosis with polyangiitis (Wegener's),
      microscopic polyangiitis, Churg Strauss syndrome, polyarteritis nodosa, giant cell arteritis,
      Takayasu arteritis). We, the investigators, will do this by studying a large group of
      patients with vasculitis and comparing them to a large group of patients that present in a
      similar way, but do not have vasculitis. By comparing the 2 groups we will create a list of
      items to differentiate between vasculitis and 'vasculitis mimics'.

      We also aim to update the current classification criteria. Classification criteria are used
      to group patients into different types of vasculitis, once a diagnosis of vasculitis has been
      made, and are useful for studying patients in clinical trials with similar or identical
      diseases. The current classification criteria (American college of Rheumatology 1990
      criteria) were developed 20 years ago, before the availability of some important diagnostic
      tests (e.g. antineutrophil cytoplasmic antibodies [ANCA]), and are now not consistent with
      some of the current disease definitions. Therefore to progress future research in vasculitis,
      it is important that the classification criteria are updated. We will recruit 260 patients
      with each of the 6 types of vasculitis and compare them with 1300 controls (patients with the
      5 other types of vasculitis), in order to determine the optimal combination of symptoms,
      signs and investigations that classify each person into the appropriate group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The systemic vasculitides are a group of uncommon but important diseases whose prognosis has
      improved dramatically with the use of immunosuppressive therapy. However, long-term morbidity
      from recurrent disease flares, low-grade grumbling disease and/or accumulating damage from
      previous disease activity or drug therapy now characterise the long-term outlook for patients
      with vasculitis. There remains major controversy, and incompatibility between the
      ANCA-associated vasculitides: granulomatosis with polyangiitis (Wegener's), microscopic
      polyangiitis, and Churg Strauss Syndrome, as well as polyarteritis nodosa in the current
      classification criteria and disease definitions. Importantly, there are no diagnostic
      criteria for any of the primary systemic vasculitides.

      We propose to improve existing classification criteria for the primary systemic vasculitides.
      As a starting point will include the following diseases: granulomatosis with polyangiitis
      (Wegener's) (GPA), microscopic polyangiitis (MPA), Churg Strauss syndrome (CSS),
      polyarteritis nodosa (PAN), giant cell arteritis (GCA) and Takayasu arteritis (TAK).

      We propose to develop and validate classification and diagnostic criteria for primary
      systemic vasculitis using the guidelines suggested by the Classification and Response
      Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures.
      For all patients, a detailed medical history, physical examination, laboratory tests
      (including ANCA), radiology (including angiography), biopsy results, treatment, Birmingham
      Vasculitis Activity Score (BVAS)version 3, Vasculitis Damage Index (VDI), will be collected.
      The exact list of items to be recorded will be determined by the expert panel at the start of
      the study.

      Classification criteria

      We will study a minimum of 100 patients (new and existing patients) prospectively within each
      currently defined disease category (GPA, CSS, MPA, PAN, GCA, TAK) for the development of the
      classification criteria. We anticipate the need to recruit 130 patients to account for
      misdiagnosis and dropout to achieve the target of 100 with the confirmed reference diagnosis.
      This will include patients that have vasculitis which are assumed to be related to ANCA but
      do not fulfil the current definitions of any of the diseases, and patients with large vessel
      vasculitis which do not fulfil current definition for GCA or TAK. Therefore new categories of
      disease may be created as part of this process and some of the current disease categories may
      be changed to include or exclude certain patients.

      The other diseases will be the controls. The same minimum number of patients will be used to
      validate the criteria. The 1st 100 patients with a formal reference diagnosis that are
      recruited for each disease will be used for development of the classification criteria; the
      next 100 consecutive patients recruited with a confirmed reference diagnosis for each disease
      will be used to validate the criteria. Again we anticipate the need to recruit 130 patients
      to account for misdiagnosis and dropout to achieve the 100 target. The majority of cases
      included will be the same as that used for the development of the diagnostic criteria.

      In the absence of an established gold standard, we propose to develop a reference standard.
      Clinical vignettes using clustering of clinical features and investigations will be
      constructed from actual cases by the steering group. An expert panel will then be asked to
      classify each vignette. Hypothetical changes will then be made to components of each clinical
      vignette and the expert panel will be asked to re classify the case. This process will be
      repeated multiple times in an attempt to determine what key clinical feature influence the
      expert panel to change the diagnosis. Using this data driven process, a construct of
      important clinical features for each disease will be determined by the expert panel. Using
      this new construct, patients will be classified by the expert panel. This will form the
      reference standard against which the new criteria will be tested.

      Diagnostic Criteria

      We propose to develop and validate diagnostic criteria for primary systemic vasculitis. Based
      on current disease categories we will include GPA, MPA, CSS, PAN, GCA and TAK (but this may
      change depending on whether new categories are created or existing categories merged as part
      of the classification criteria component). For the development of diagnostic criteria, we
      will study a minimum of 100 patients (will require approx 130 patients to allow for dropout
      and misdiagnosis) for each disease category. Assuming 6 disease categories, the majority of
      these 780 patients will have already been identified from the classification criteria
      component of the study and will be re used for the development and validation of diagnostic
      criteria. However, for the diagnostic criteria to be clinically relevant we will only include
      patients that are seen at the time of 1st presentation, therefore not all the 780 patients
      recruited for the classification criteria section of the study will be suitable, and we will
      need to recruit additional new patients for each of the types of vasculitis being studied.

      We will use a minimum of 400 context specific controls (patients that don't have vasculitis)
      for AAV and PAN that will cover the spectrum of different disease presentations and severity.
      In addition, we will recruit a minimum of 100 context specific controls for GCA and a similar
      number for TAK. Different control populations are needed for AAV, GCA and TAK as they have
      significantly different clinical presentations. In a similar manner to cases, we will recruit
      30% more patients than the minimum required to account for misdiagnosis and drop out. The
      same minimum number of cases and controls will be needed to validate the criteria. The first
      half of the patients recruited would be used to develop the criteria, and the 2nd half to
      validate the criteria. We will allow inclusion of patients from previously studied
      prospective cohorts that meet all the appropriate inclusion / exclusion criteria and have had
      all the appropriate clinical information and mandatory investigation (to be defined later)
      recorded at time of their first presentation. This is to facilitate the recruitment of
      sufficient patients with PAN, CSS and TAK which are rare conditions.

      Statistical analysis

      We will follow the ACR recommended statistical methods for creating the classification
      criteria. Patients will have been classified into the different types of vasculitis according
      to the proposed EULAR/ACR schema by the expert panel or as a vasculitis mimic. The outcomes
      of interest are binary variables indicating whether or not a patient has been classified as
      having a particular type of vasculitis, such as GPA, MPA, etc. For each outcome,
      multivariable logistic regression modeling will be used to identify predictors of outcome
      based on the list of potential predictor variables described earlier. We will also explore
      the use of Classification And Regression Tree (CART) analysis. This is a tree-building
      technique ideally suited to the generation of clinical decision rules. Unlike conventional
      regression methods, patients are partitioned (&quot;split&quot;) into different groups based on an
      exhaustive search of all possible predictor variables. The advantage of CART analysis over
      conventional methods is that it is non-parametric, so no assumptions are made about the
      underlying distribution of predictor variables. CART can handle many hundreds of possible
      predictor variables and can uncover complex interactions between predictors which may be
      difficult or impossible to uncover using traditional multivariate techniques that can suffer
      from model over fitting. In addition, clinicians generally do not think in terms of
      probability but rather in terms of categories, such as low versus high risk. Clinical
      decision rules generated using CART analysis are more likely to make clinical sense, and
      hence more likely to be followed in clinical practice.

      Once the best items are identified, the expert panel will decide on the best short list of
      items to be included in each criteria and also choose the most appropriate decision tree.
      This will provide the best content validity.

      The statistical methods to be used for diagnostic criteria will be very similar to that used
      for the classification criteria. The binary outcome for analysis is whether the person is a
      case or control (without vasculitis). We repeat the analyses for each of each type of
      vasculitis e.g. WG versus controls, then CSS versus controls etc
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Develop new diagnostic and classification criteria for ANCA associated vasculitis and polyarteritis nodosa</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>14</number_of_groups>
  <enrollment type="Anticipated">3588</enrollment>
  <condition>Wegener's Granulomatosis</condition>
  <condition>Microscopic Polyangiitis</condition>
  <condition>Churg Strauss Syndrome</condition>
  <condition>Polyarteritis Nodosa</condition>
  <condition>Giant Cell Arteritis</condition>
  <condition>Takayasu Arteritis</condition>
  <arm_group>
    <arm_group_label>WG classification</arm_group_label>
    <description>Patients with Wegener's granulomatosis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MPA classification</arm_group_label>
    <description>Patients with microscopic polyangiitis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CSS classification</arm_group_label>
    <description>Patients with Churg Strauss syndrome. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAN classification</arm_group_label>
    <description>Patients with polyarteritis nodosa. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Classification</arm_group_label>
    <description>For each of the diseases being evaluated (WG, MPA, CSS, PAN, GCA, TAK), patients with the other 5 diseases will be the control group. Within these groups, 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WG diagnostic</arm_group_label>
    <description>Patients with a new presentation of Wegener's granulomatosis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MPA diagnostic</arm_group_label>
    <description>Patients with a new presentation of microscopic polyangiitis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CSS diagnostic</arm_group_label>
    <description>Patients with a new presentation of Churg Strauss syndrome. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAN diagnostic</arm_group_label>
    <description>Patients with a new presentation of polyarteritis nodosa. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control diagnostic</arm_group_label>
    <description>Patients without vasculitis, but presenting with similar features to the 6 different types of vasculitis being studied. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GCA classification</arm_group_label>
    <description>Patients with giant cell arteritis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAK classification</arm_group_label>
    <description>Patients with Takayasu arteritis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Classification criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GCA diagnostic</arm_group_label>
    <description>Patients with a new diagnosis of giant cell arteritis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAK diagnostic</arm_group_label>
    <description>Patients with a new diagnosis of Takayasu arteritis. 1st half of these patients will be assigned to the development cohort and the second half to the validation cohort. Diagnostic criteria.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Patients may be given the option of having blood, urine or other tissue obtained as part of
      their routine care retained for use in future ethically approved studies. They may also be
      asked to provide additional blood to be stored for this purpose. This component is an
      optional extra, and does not form part of the main study.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with primary systemic vasculitis or a mimic of these diseases seen in
        participating secondary or tertiary care centres in Europe, USA, Mexico, Japan, Asia,
        Australasia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Classification criteria:

          1. Adult patients aged &gt;18 years. There is no upper age limit.

          2. Ability to give informed consent. If the patient is unable to give informed consent as
             a result of death or physical incapacity, then informed assent from next of kin.

          3. Presumed diagnosis of a primary systemic vasculitis.

        Exclusion criteria for classification criteria:

          1. Patients &lt; 18 years of age.

          2. Inability to provide informed consent.

          3. Hepatitis B or C

          4. Co-morbidities that explain the clinical symptoms and signs on which the diagnosis of
             vasculitis is made. E.g. infection, tumour, other inflammatory condition, etc.

        Inclusion criteria for diagnostic criteria:

          1. Adult patients aged &gt;18 years. There is no upper age limit.

          2. Ability to give informed consent. If the patient is unable to give informed consent as
             a result of death or physical incapacity, then informed assent from next of kin.

          3. Suspected diagnosis of a primary systemic vasculitis

        Inclusion criteria for controls group for diagnostic criteria:

          1. Adult patients aged &gt;18 years. There is no upper age limit.

          2. Ability to give informed consent. If the patient is unable to give informed consent as
             a result of death or physical incapacity, then informed assent from next of kin.

          3. Patients presenting to secondary care with one of the following clinical
             presentations: I.Multi-system disease. Presentation of disease with at least 2 organs
             involved. II.Pulmonary-renal syndrome. Defined as haemoptysis / pulmonary haemorrhage
             with acute renal impairment. III.Acute renal failure IV.Acute respiratory distress.
             V.Chronic upper airways symptoms and signs. VI.Inflammatory polyarthritis. VII.Fever
             of unknown origin. VIII.Acute or chronic abdominal pain IX.Hypertension. X.Referred to
             secondary care with suspicion of vasculitis but confirmed not to have vasculitis.
             XII.New onset headache. XIII.Jaw or tongue pain. XIV.Sudden visual loss. XV.Limb
             claudication. XVI.Aortic aneurysm &gt;5cm.

        Exclusion Criteria for diagnostic criteria:

          1. Patients under the age of 18

          2. Patient or next of kin unable or unwilling to provide informed consent or assent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raashid A Luqmani, DM, FRCP(E)</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford, United Kingdom</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Merkel, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Watts, DM, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of East Anglia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raashid A Luqmani</last_name>
    <phone>+44 1865 738106</phone>
    <email>raashid.luqmani@ndorms.ox.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anthea Craven</last_name>
    <email>anthea.craven@ndorms.ox.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelo Gaffo</last_name>
      <email>agaffo@uab.edu</email>
    </contact>
    <investigator>
      <last_name>Angelo Gaffo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center, LA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Weisman</last_name>
      <email>Weisman@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Michael Weisman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-0500</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Chung</last_name>
      <email>sharon.chung@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Sharon Chung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamal Mikdashi</last_name>
      <email>jmikdash@umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Jamal Mikdashi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vasculitis Center, Boston University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Grayson</last_name>
      <email>peter.grayson@bmc.org</email>
    </contact>
    <investigator>
      <last_name>Peter Grayson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan, Internal Medicine</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William J McCune</last_name>
      <email>jmccune@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ora Gewurz-Singer</last_name>
    </contact_backup>
    <investigator>
      <last_name>Professor William J McCune</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Matteson</last_name>
      <email>matteson.eric@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Matteson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Centre, Lebanon, NH</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel A Albert</last_name>
      <email>Daniel.A.Albert@Hitchcock.ORG</email>
    </contact>
    <investigator>
      <last_name>Daniel A Albert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Centre</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yusuf Yazici</last_name>
      <email>yusuf.yazici@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Yusuf Yazici</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7525</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charles Jennette</last_name>
      <email>jcj@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Jennette</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ronald Falk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Langford</last_name>
      <email>LANGFOC@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Leonard Calabrese</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter A Merkel</last_name>
      <email>pmerkel@upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Peter A Merkel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Liang</last_name>
      <email>liangkp@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Kim Liang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132-0002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Curry Koening</last_name>
      <email>curry.koening@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Curry Koening</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Interzonal San Juan Bautista</name>
      <address>
        <city>San Fernando del Valle de Catamarca</city>
        <state>Catamarca</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Toloza</last_name>
      <email>sergiotol@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Sergio Toloza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ramos Mejia Hospital, University of Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1221ADC</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Kerzberg</last_name>
      <email>eduardomariok@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo Kerzberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ANU Medical Centre</name>
      <address>
        <city>Canberra</city>
        <state>Australian Capital Territory</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Gatenby</last_name>
      <email>paul-gatenby@anu.edu.au</email>
    </contact>
    <investigator>
      <last_name>Paul Gatenby</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dwarakanathan Ranganathan</last_name>
      <email>Dwarakanathan_Ranganathan@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Dwarakanathan Ranganathan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Kronbichler</last_name>
      <email>Andreas.Kronbichler@i-med.ac.at</email>
    </contact>
    <investigator>
      <last_name>Andreas Kronbichler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Blockmans</last_name>
      <email>Daniel.Blockmans@uz.kuleuven.ac.be</email>
    </contact>
    <investigator>
      <last_name>Daniel Blockmans</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A 1M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Navjot Dhindsa</last_name>
      <email>ndhindsa@hsc.mb.ca</email>
    </contact>
    <investigator>
      <last_name>Navjot Dhindsa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Joseph's Healthcare</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nader Khalidi</last_name>
      <email>naderkhalidi@sympatico.ca</email>
    </contact>
    <investigator>
      <last_name>Nader Khalidi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1N 6N5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nataliya Milman</last_name>
      <email>nmilman@Ottawahospital.on.ca</email>
    </contact>
    <investigator>
      <last_name>Nataliya Milman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital, Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>ON M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Carette</last_name>
      <email>Simon.Carette@uhn.on.ca</email>
    </contact>
    <investigator>
      <last_name>Simon Carette</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 0G4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Pineau</last_name>
      <email>christian.pineau@mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Christian Pineau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sherbrooke University Hospital Centre</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Liang</last_name>
      <email>patrick.liang@usherbrooke.ca</email>
    </contact>
    <investigator>
      <last_name>Patrick Liang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Walsh</last_name>
      <email>mwwalsh@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Walsh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Joseph's Healthcare London, Ontario</name>
      <address>
        <city>Ontario</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lillian Barra</last_name>
    </contact>
    <investigator>
      <last_name>Lillian Barra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital, Beijing</name>
      <address>
        <city>Beijing</city>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinping Tian</last_name>
      <email>tianxp6@126.com</email>
    </contact>
    <investigator>
      <last_name>Xinping Tian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General University Hospital, Prague</name>
      <address>
        <city>Prague</city>
        <zip>128 08</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Tesar</last_name>
      <email>vladimir.tesar@lf1.cuni.cz</email>
    </contact>
    <investigator>
      <last_name>Vladimir Tesar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General University Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladamir Tesar</last_name>
    </contact>
    <investigator>
      <last_name>Vladamir Tesar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neils Rasmussen</last_name>
      <email>nrasent@dadlnet.dk</email>
    </contact>
    <investigator>
      <last_name>Niels Rasmussen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bo Baslund</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assiut University, Assiut University Hospitals</name>
      <address>
        <city>Assiut</city>
        <zip>71516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nevin Hammam</last_name>
      <email>nevin.hammam@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nevin Hammam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cairo University, Kasr El Ainy Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amira Shahin</last_name>
      <email>amirashahin@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Amira Shahin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jukka Putaala</last_name>
      <email>jukka.putaala@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Jukka Putaala</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cochin Hospital, Université Paris-descartes</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Guillevin</last_name>
      <email>loic.guillevin@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Loic Guillevin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743 Jena</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Neumann</last_name>
      <email>Thomas.Neumann@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Neumann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Schleswig-Holstein</name>
      <address>
        <city>Luebeck</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Holle</last_name>
      <email>hollejulia@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Julia Holle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cord Sunderkötter</last_name>
      <email>Cord.Sunderkoetter@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Cord Sunderkötter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kreiskliniken Esslingen</name>
      <address>
        <city>Plochingen</city>
        <zip>73207</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Hellmich</last_name>
      <email>b.hellmich@kk-es.de</email>
    </contact>
    <investigator>
      <last_name>Bernhard Hellmich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joerg Henes</last_name>
      <email>joerg.henes@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Joerg Henes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Debrecen Medical and Health Science Center</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoltan Szekanecz</last_name>
      <email>szekanecz.zoltan@med.unideb.hu</email>
    </contact>
    <investigator>
      <last_name>Zoltan Szekanecz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chatrapathi Shahuji Maharaj Medical Center, Lucknow (IProcess)</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siddhart Das</last_name>
    </contact>
    <investigator>
      <last_name>Siddhart Das</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Postgraduate Institute of Medical Education and Research, Chandigarh</name>
      <address>
        <city>Chandigarh</city>
        <zip>Pin- 160 012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aman Sharma</last_name>
      <email>pgimer-chd@nic.in</email>
    </contact>
    <investigator>
      <last_name>Aman Sharma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nizam's Institute of Medical Sciences, Hyderabad</name>
      <address>
        <city>Hyderabad</city>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liza Rajasekhar</last_name>
      <email>lizarajasekhar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Liza Rajasekhar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medanta, Delhi</name>
      <address>
        <city>New Delhi</city>
        <zip>110024</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajiva Gupta</last_name>
      <email>guptarajiva@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Rajiva Gupta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christian Medical College &amp; Hospital, Vellore</name>
      <address>
        <city>Vellore</city>
        <zip>632 004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debashish Danda</last_name>
      <email>debashish.danda@cmcvellore.ac.in</email>
    </contact>
    <investigator>
      <last_name>Debashish Danda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cork University Hospital</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Clarkson</last_name>
      <email>michael.clarkson@hse.ie</email>
    </contact>
    <investigator>
      <last_name>Michael Clarkson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's University Hospital, Dublin</name>
      <address>
        <city>Dublin 4</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eamonn Molloy</last_name>
      <email>E.Molloy@st-vincents.ie</email>
    </contact>
    <investigator>
      <last_name>Eamonn Molloy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Parma</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augusto Vaglio</last_name>
      <email>augusto.vaglio@virgilio.it</email>
    </contact>
    <investigator>
      <last_name>Augusto Vaglio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Maria Nuova Hospital, Reggio Emilia</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Salvarani</last_name>
      <email>Carlo.Salvarani@asmn.re.it</email>
    </contact>
    <investigator>
      <last_name>Carlo Salvarani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcispedale Santa Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Salvarani</last_name>
      <email>Carlo.Salvarani@asmn.re.it</email>
    </contact>
    <investigator>
      <last_name>Carlo Salvarani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kameda Medical Centre, Kamogawa</name>
      <address>
        <city>Kamogawa City</city>
        <state>Chiba prefecture</state>
        <zip>296-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazuo Matsui</last_name>
      <email>pxu17054@nifty.com</email>
    </contact>
    <investigator>
      <last_name>Kazuo Matsui</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tsukuba University Hospital</name>
      <address>
        <city>Tsukuba</city>
        <state>Ibaraki Prefecture</state>
        <zip>305-8576</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kunihiro Yamagata</last_name>
    </contact>
    <investigator>
      <last_name>Kunihiro Yamagata</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miyazaki University Hospital</name>
      <address>
        <city>Miyazaki City</city>
        <state>Miyazaki Prefecture</state>
        <zip>889-1692</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shouichi Fujimoto</last_name>
    </contact>
    <investigator>
      <last_name>Shouichi Fujimoto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saitama Medical University</name>
      <address>
        <city>Kawagoe</city>
        <state>Saitama Prefecture</state>
        <zip>350-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koichi Amano</last_name>
      <email>amanokoi@saitama-med.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Koichi Amano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyorin University Hospital</name>
      <address>
        <city>Mitaka</city>
        <state>Tokyo Prefecture</state>
        <zip>181-8611</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoshihiro Arimura</last_name>
    </contact>
    <investigator>
      <last_name>Yoshihiro Arimura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chiba University</name>
      <address>
        <city>Chiba</city>
        <zip>260-8670</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazuo Suzuki</last_name>
      <email>ksuzuki@faculty.chiba-u.jp</email>
    </contact>
    <investigator>
      <last_name>Kazuo Suzuki</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kagawa University Hospital</name>
      <address>
        <city>Kagawa</city>
        <zip>761-0793</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroaki Dobashi</last_name>
    </contact>
    <investigator>
      <last_name>Hiroaki Dobashi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Marianna University Hospital</name>
      <address>
        <city>Kanagawa</city>
        <zip>216-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hidehiro Yamada</last_name>
      <email>guriko@marianna-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Hidehiro Yamada</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kanazawa University Hospital</name>
      <address>
        <city>Kanazawa</city>
        <zip>920-8641</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takashi Wada</last_name>
      <email>twada@medf.m.kanazawa-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Takashi Wada</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Okayama University Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>700-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hirofumi Makino</last_name>
    </contact>
    <investigator>
      <last_name>Hirofumi Makino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kitano Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eri Muso</last_name>
    </contact>
    <investigator>
      <last_name>Eri Muso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juntendo University Koshigaya Hospital</name>
      <address>
        <city>Saitama</city>
        <zip>343-0032</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shigeto Kobayashi</last_name>
    </contact>
    <investigator>
      <last_name>Shigeto Kobayashi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jichi Medical University Hospital</name>
      <address>
        <city>Tochigi-ken</city>
        <zip>3311-1 Yakushiji</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wako Yumura</last_name>
    </contact>
    <investigator>
      <last_name>Wako Yumura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Tokyo Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>113-8655</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junichi Hirahashi</last_name>
      <email>jhirahashi-tky@umin.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Junichi Hirahashi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeong-Wook Song</last_name>
      <email>ysong@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Yeong-Wook Song</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Enfermedades Respiratorias</name>
      <address>
        <city>Mexico City</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Felipe Flores-Suárez</last_name>
      <email>felipe98@prodigy.net.mx</email>
    </contact>
    <investigator>
      <last_name>Luis Felipe Flores-Suárez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Hinojosa</last_name>
    </contact>
    <investigator>
      <last_name>Andrea Hinojosa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>6Z 165</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maarten Boers</last_name>
      <email>mboers56@xs4all.nl</email>
    </contact>
    <investigator>
      <last_name>Maarten Boers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>30.001</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abraham Rutgers</last_name>
      <email>a.rutgers@umgc.nl</email>
    </contact>
    <investigator>
      <last_name>Abraham Rutgers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Otago, Christchurch</name>
      <address>
        <city>Christchurch</city>
        <state>Canterbury</state>
        <zip>8011</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Stamp</last_name>
      <email>Lisa.Stamp@cdhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Lisa Stamp</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland District Health Board</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ravi Suppiah</last_name>
    </contact>
    <investigator>
      <last_name>Ravi Suppiah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Waitemata District Health Board, North Shore Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Janak de Zoysa</last_name>
      <email>janak.dezoysa@waitematadhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Janak de Zoysa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Waikato District Health Board</name>
      <address>
        <city>Hamilton</city>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicky Quincey</last_name>
      <email>vicki.quincey@waikatodhb.health.nz</email>
    </contact>
    <investigator>
      <last_name>Vicky Quincey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Southern Norway</name>
      <address>
        <city>Kristiansand</city>
        <zip>Post box 416, 4605</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Diamantopoulos</last_name>
      <phone>+47 38073155</phone>
      <email>andreas.diamantopoulos@sshf.no</email>
    </contact>
    <investigator>
      <last_name>Andreas Diamantopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University Hospital of Northern Norway, Tromsø</name>
      <address>
        <city>Tromsø</city>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilio Besada</last_name>
      <email>Emilio.Besada@unn.no</email>
    </contact>
    <investigator>
      <last_name>Emilio Besada</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Jagiellonian</name>
      <address>
        <city>Kraków</city>
        <zip>31-007</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Sznajd</last_name>
      <email>jsznajd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jan Sznajd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Garcia de Orta, Almada</name>
      <address>
        <city>Almada</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Rodrigues</last_name>
      <email>mig.rodrigues69@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Miguel Rodrigues</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Maria Hospital, Lisbon</name>
      <address>
        <city>Lisbon</city>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Geraldes</last_name>
      <email>ruth.geraldes@netcabo.pt</email>
    </contact>
    <investigator>
      <last_name>Ruth Geraldes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santo Antonio, Porto</name>
      <address>
        <city>Porto</city>
        <zip>4099 - 001</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernestina Santos</last_name>
      <email>ernestina.santos@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ernestina Santos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Moscow State Medical University</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergey Moiseev</last_name>
      <email>clinpharm@mtu-net.ru</email>
    </contact>
    <investigator>
      <last_name>Sergey Moiseev</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pavel Novikov</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alojzija Hočevar</last_name>
      <email>alojzija.hocevar@siol.net</email>
    </contact>
    <investigator>
      <last_name>Alojzija Hočevar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic Barcelona Hospital Universitari</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cid</last_name>
      <email>MCCID@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Maria Cid</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colombo</name>
      <address>
        <city>Columbo 8</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inoshi Atukorala</last_name>
      <email>inoshi.atu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Inoshi Atukorala</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lund University</name>
      <address>
        <city>Lund</city>
        <zip>SE-221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aladdin Mohammad</last_name>
      <email>aladdin.mohammad@med.lu.se</email>
    </contact>
    <investigator>
      <last_name>Mårten Segelmark</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska Institute, Stockholm</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johan Bratt</last_name>
      <email>johan.bratt@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Johan Bratt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linköping University</name>
      <address>
        <city>Stockholm</city>
        <zip>581 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marten Segelmark</last_name>
      <email>marten.segelmark@liu.se</email>
    </contact>
    <investigator>
      <last_name>Marten Segelmark</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Umeå University</name>
      <address>
        <city>Umeå</city>
        <zip>901 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ewa Berglin</last_name>
      <email>ewa.berglin@vll.se</email>
    </contact>
    <investigator>
      <last_name>Ewa Berglin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ann Knight</last_name>
      <email>ann.kataja.knight@akademiska.se</email>
    </contact>
    <investigator>
      <last_name>Ann Knight</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Daikeler</last_name>
      <email>tdaikeler@uhvs.ch</email>
    </contact>
    <investigator>
      <last_name>Thomas Daikeler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Immunologie-Zentrum Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Hauser</last_name>
      <email>hauser@immunologie-zentrum.ch</email>
    </contact>
    <investigator>
      <last_name>Thomas Hauser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hacettepe University</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omer Karadag</last_name>
      <email>omerkaradag@ymail.com</email>
    </contact>
    <investigator>
      <last_name>Omer Karadag</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istanbul University, Cerrahpasa Medical School</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulen Hatemi</last_name>
      <email>gulen.hatemi@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Gulen Hatemi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marmara University Medical School</name>
      <address>
        <city>Istanbul</city>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haner Direskeneli</last_name>
      <email>hanerdireskeneli@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Haner Direskeneli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fatih University Medical Faculty</name>
      <address>
        <city>Istanbul</city>
        <zip>34844</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seval Pehlivan</last_name>
      <email>sevalpehlevan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Seval Pehlivan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haydarpasa Education and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hasan Yazici</last_name>
      <email>hyazici@attglobal.net</email>
    </contact>
    <investigator>
      <last_name>Hasan Yazici</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istanbul University, Istanbul Medical School</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevil Kamali</last_name>
      <email>sevilkamali@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Sevil Kamali</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Cumbria University Hospitals, The Cumberland Infirmary</name>
      <address>
        <city>Carlisle</city>
        <state>Cumbria</state>
        <zip>CA2 7HY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alaa Hassan</last_name>
      <email>Alaa.Hassan@ncuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Alaa Hassan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Basildon and Thurrock University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nagui Gendi</last_name>
    </contact>
    <investigator>
      <last_name>Nagui Gendi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen's Hospital</name>
      <address>
        <city>Romford</city>
        <state>Essex</state>
        <zip>RM7 0AG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kuntal Chakravarty</last_name>
      <email>kuntal@talk21.com</email>
    </contact>
    <investigator>
      <last_name>Kuntal Chakravarty</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southend University Hospital NHS Trust</name>
      <address>
        <city>Westcliff-on-Sea</city>
        <state>Essex</state>
        <zip>SS0 0RY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bhaskar Dasgupta</last_name>
      <email>Bhaskar.Dasgupta@southend.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Bhaskar Dasgupta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NHS Fife, Whyteman's Brae Hospital, Windygates</name>
      <address>
        <city>Kirkcaldy</city>
        <state>Fife</state>
        <zip>KY8 5PR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Mclaren</last_name>
      <email>john.mclaren2@nhs.net</email>
    </contact>
    <investigator>
      <last_name>John Mclaren</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aberdeen Royal Infirmary</name>
      <address>
        <city>Aberdeen</city>
        <state>Scotland</state>
        <zip>AB25 2ZN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Basu</last_name>
      <email>neilbasu@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Neil Basu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NHS Greater Glasgow &amp; Clyde, Gartnavel Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G12 8TA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iain McInnes</last_name>
      <email>iain.mcinnes@glasgow.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Iain McInnes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ipswich Hospital NHS Trust</name>
      <address>
        <city>Ipswich</city>
        <state>Suffolk</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Watts</last_name>
      <email>richard.watts2@mac.com</email>
    </contact>
    <investigator>
      <last_name>Professor Richard Watts</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epsom and St Helier University Hospitals NHS Trust</name>
      <address>
        <city>Carshalton</city>
        <state>Surrey</state>
        <zip>SM5 1AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjeev Patel</last_name>
    </contact>
    <contact_backup>
      <last_name>Ritu Malaiya</last_name>
      <email>ritumalaiya@doctors.org.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Sanjeev Patel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Birmingham</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Morgan</last_name>
      <email>m.d.morgan@bham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Caroline Savage</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Jayne</last_name>
      <email>david.jayne@addenbrookes.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>David Jayne</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dudley Group of Hospitals, NHS FT</name>
      <address>
        <city>Dudley</city>
        <zip>DY1 2HQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Kloche</last_name>
      <phone>0044 1384 244807</phone>
    </contact>
    <investigator>
      <last_name>Rainer Kloche</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust, Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Mason</last_name>
      <email>justin.mason@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Justin Mason</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Manchester, Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Bruce</last_name>
      <email>ian.bruce@manchester.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ian Bruce</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Harper</last_name>
      <email>LAURA.HARPER@nnuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Chetan Mukhtyar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals NHS Trust (QMC)</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lanyon</last_name>
      <email>Peter.Lanyon@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Peter Lanyon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nuffield Orthopaedic Centre</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raashid Luqmani</last_name>
      <email>raashid.luqmani@noc.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Raashid Luqmani</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanna Robson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Trust (The Churchill Hospital)</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Hoyles</last_name>
      <email>rachel.hoyles@ouht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Rachel Hoyles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Berkshire NHS Trust</name>
      <address>
        <city>Reading</city>
        <zip>RG1 5AN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Flossmann</last_name>
      <phone>0118 3225308</phone>
      <email>oliver.flossman@royalberkshire.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Oliver Flossmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heatherwood &amp; Wexham Park Hospitals NHS Foundation Trust</name>
      <address>
        <city>Slough</city>
        <zip>SL2 4HL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Adler</last_name>
      <email>Matthew.Adler@hwph-tr.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Matthew Adler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton University Hospitals NHS Trust</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>York Hospital NHS Foundation Trust</name>
      <address>
        <city>York</city>
        <zip>YO31 8HE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colin Jones</last_name>
      <email>Colin.H.Jones@York.NHS.UK</email>
    </contact>
    <investigator>
      <last_name>Colin Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Egypt</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Sri Lanka</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vasculitis.org</url>
    <description>Website for European Vasculitis Study Group (EUVAS)</description>
  </link>
  <reference>
    <citation>Singh JA, Solomon DH, Dougados M, Felson D, Hawker G, Katz P, Paulus H, Wallace C; Classification and Response Criteria Subcommittee of the Committee on Quality Measures, American College of Rheumatology. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum. 2006 Jun 15;55(3):348-52.</citation>
    <PMID>16739201</PMID>
  </reference>
  <reference>
    <citation>Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998 Sep 1;129(5):345-52.</citation>
    <PMID>9735061</PMID>
  </reference>
  <reference>
    <citation>Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990 Aug;33(8):1065-7.</citation>
    <PMID>2390119</PMID>
  </reference>
  <reference>
    <citation>Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990 Aug;33(8):1135-6.</citation>
    <PMID>2202312</PMID>
  </reference>
  <reference>
    <citation>Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187-92. Review.</citation>
    <PMID>8129773</PMID>
  </reference>
  <reference>
    <citation>Sørensen SF, Slot O, Tvede N, Petersen J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis. 2000 Jun;59(6):478-82.</citation>
    <PMID>10834866</PMID>
  </reference>
  <reference>
    <citation>Felson DT, Anderson JJ. Methodological and statistical approaches to criteria development in rheumatic diseases. Baillieres Clin Rheumatol. 1995 May;9(2):253-66. Review.</citation>
    <PMID>7656339</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2010</study_first_submitted>
  <study_first_submitted_qc>February 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2010</study_first_posted>
  <last_update_submitted>August 18, 2016</last_update_submitted>
  <last_update_submitted_qc>August 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Classification criteria</keyword>
  <keyword>Diagnostic criteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Systemic Vasculitis</mesh_term>
    <mesh_term>Granulomatosis with Polyangiitis</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
    <mesh_term>Microscopic Polyangiitis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
    <mesh_term>Churg-Strauss Syndrome</mesh_term>
    <mesh_term>Polyarteritis Nodosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

